Cyclophosphamide

CAS 50-18-0 15 API suppliersSmall Molecule

Overview

Cyclophosphamide is an alkylating agent used in the treatment of various types of cancer and certain autoimmune diseases. It works by interfering with the growth and replication of cancer cells.

API suppliers (15)

Suppliers of Cyclophosphamide evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

Where these suppliers are
India5United States3China2Taiwan1

Country recorded for 11 of 15 suppliers.

4 of 15 hold a GMP certificate on record in the EU or UK registers

Patent & exclusivity (US)

Per the FDA Orange Book (54 approved US products), the latest listed US patent on Cyclophosphamide expires 15 Feb 2036. Generic API sourcing typically opens up once these lapse.

Therapeutic areas

OncologyRheumatology
Verified Supplier Partner

Do you supply Cyclophosphamide? Get in front of buyers actively sourcing it.

We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.

No cost to enquire · we only reach out with a fit.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.